Patients first, BRIVIACT first
Start and stay
for their long-term
journey
with BRIVIACT Approved for patients as young as
1 month of age1Long-term retention data available2,3
living with focal seizures.
Discover SGTC seizure freedom data
See safety and
tolerabilityLearn about savings and support for eligible patients
Multiple formulations offer flexible administration1
Products not shown at actual size.
BRIVIACT injection may be used when oral administration is temporarily not feasible.1
SGTC=secondarily generalized tonic-clonic.
References: 1. BRIVIACT® (brivaracetam) prescribing information. Smyrna, GA: UCB, Inc. 2. Toledo M, Whitesides J, Schiemann J, et al. Safety, tolerability, and seizure control during long-term treatment with adjunctive brivaracetam for partial-onset seizures. Epilepsia. 2016;57(7):1139-51. doi: 10.1111/epi.13416. 3. Data on file. UCB, Inc.